Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials (Q35792547)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 September 2015

Language	Label	Description	Also known as
English	Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials	scientific article published on 30 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

0 references

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hans-Peter Brunner-La Rocca

1

object named as

Hans-Peter Brunner-La Rocca

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

3

object named as

A Mark Richards

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

4

object named as

James L Januzzi

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Christopher M O'Connor

12

object named as

Christopher M O'Connor

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

15

object named as

Christopher M Frampton

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

16

object named as

M Gary Nicholls

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Richard Troughton

17

object named as

Richard W Troughton

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

14

object named as

Hanna K Gaggin

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Matthias E Pfisterer

5

object named as

Matthias E Pfisterer

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

7

object named as

Yigal M Pinto

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Luc Eurlings

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ulf Dahlström

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Patric Karlström

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Hans Erntell

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Rudolf Berger

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Hans Persson

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Deddo Moertl

13

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

30 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1252-1261

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Spironolactone for heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT‐proBNP Guided Management of Heart Failure – SIGNAL‐HF (Swedish Intervention study – Guidelines and NT‐proBNP AnaLysis in Heart Failure)

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Assessing kidney function--measured and estimated glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Polypharmacy in heart failure patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Incidence and prevalence of heart failure in elderly persons, 1994-2003.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Outcome of heart failure with preserved ejection fraction in a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart Failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

21 January 2018

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of worsening renal function related to medication in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.401

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.401

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35792547&oldid=1755171034"